MapLight Therapeutics, Inc. (MPLT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for MapLight Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Valuation | ||||
| P/E Ratio | -4.80x | -9.79x | -13.64x | -25.31x |
| P/B Ratio | 1.69x | 6.60x | 10.66x | 36.41x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||
| Current Ratio | 20.01x | 7.20x | 5.69x | 2.54x |
| Quick Ratio | 20.01x | 7.20x | 5.69x | 2.54x |
| Leverage | ||||
| Debt/Equity | 0.01x | 0.06x | 0.08x | 0.30x |
YoY = year-over-year change. Source: FMP..